Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression (2010)
- Authors:
- USP affiliated authors: DOREA, EGIDIO LIMA - HU ; HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: HU; FCF
- Subjects: POLIMORFISMO; COLESTEROL
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical Chemistry and Laboratory Medicine
- ISSN: 1437-4331
- Volume/Número/Paginação/Ano: v. 48, n. 8, p. A64-A64 res. B4, 2010
- Conference titles: Santorini Conference Biologie Prospective
-
ABNT
CERDA, Alvaro et al. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 18 abr. 2024. , 2010 -
APA
Cerda, A., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R., Dórea, E. L., et al. (2010). Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo. -
NLM
Cerda A, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Dórea EL, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A64-A64 res. B4.[citado 2024 abr. 18 ] -
Vancouver
Cerda A, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Dórea EL, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A64-A64 res. B4.[citado 2024 abr. 18 ] - Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
- Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin
- The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
- Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
- Expression of inflammatory response genes in pbmc from type 2 diabetes individuals treated with simvastatin and ezetimibe
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas